≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Lymphoid leukaemia

Endpoint Browser PheWeb

CD2_LYMPHOID_LEUKAEMIA_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C91
  • Hospital discharge: ICD-9 — 204
  • Hospital discharge: ICD-8 — 204
  • Cause of death: ICD-10 — C91
  • Cause of death: ICD-9 — 204
  • Cause of death: ICD-8 — 204

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
C81-C96
Name in latin
Leuc(h)aemia lymphatica

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 2041 789 1252
Unadjusted period prevalence (%) 0.44 0.27 0.55
Median age at first event (years) 65.11 62.88 66.51

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1871
Matched controls
18711
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
XW000
NOMESCO Finland
Bone marrow biopsy
48.1
323.0
662
210
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
323.0
698
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
16384.0
323.0
1364
*
L03AA02
ATC
filgrastim; parenteral
489.2
323.0
360
9
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
193.7
323.0
1036
119
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
323.0
402
*
A04AA01
ATC
ondansetron; systemic, rectal
37.3
314.7
407
138
H02AB02
ATC
dexamethasone; systemic
44.5
234.4
291
77
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
107.7
232.9
252
27
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
12.9
230.7
436
430
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
213.7
201
*
M04AA01
ATC
allopurinol; systemic
5.8
195.6
661
1597
L03AA13
ATC
pegfilgrastim; parenteral
+∞
195.3
184
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
+∞
194.2
183
*
JN4BD
NOMESCO Finland
Extensive body CT
11.3
187.7
377
409
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
1996.2
181.2
173
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
175.8
166
*
WW500
NOMESCO Finland
Blood transfusion
19.4
174.6
273
163
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.9
167.1
539
1196
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
360.4
163.8
163
5
L01AA02
ATC
chlorambucil; oral
836.2
158.9
154
*
L01BB05
ATC
fludarabine; systemic
+∞
158.6
150
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
524.5
148.7
146
*
L01BB02
ATC
mercaptopurine; oral
52.7
147.4
177
37
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
133.7
139.3
148
12
C61
ICD-10 Finland
Malignant neoplasm of prostate
298.6
137.3
138
5
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
40.5
134.5
170
46
R50.9
ICD-10 Finland
Fever, unspecified
4.9
134.4
516
1354
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
132.9
126
*
ZX120
NOMESCO Finland
Intravenous
6.4
122.4
353
654
A04AA02
ATC
granisetron; systemic, transdermal
412.4
117.9
117
*
J05AB11
ATC
valaciclovir; oral
5.0
117.4
433
1071
B73
ICPC
Leukaemia
1154.8
112.8
109
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
112.6
107
*
C91.7
ICD-10 Finland
Other lymphoid leukaemia
+∞
109.4
104
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
24.4
107.8
155
69
390
Kela drug reimbursment
Ibrutinib
+∞
100.9
96
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.7
100.4
389
997
H02AB09
ATC
hydrocortisone; systemic
14.7
99.5
172
128
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
97.7
93
*
TAB00
NOMESCO Finland
Lumbar puncture
8.1
96.0
229
317
C91.4
ICD-10 Finland
Hairy-cell leukaemia
+∞
95.6
91
*
130
Kela drug reimbursment
Malignant tumour
+∞
95.6
91
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
9.1
95.4
211
258
C90.0
ICD-10 Finland
Multiple myeloma
+∞
94.6
90
*
1512
Kela drug reimbursment
Ibrutinib
+∞
93.5
89
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
91.4
87
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
909.9
89.5
87
*
116
Kela drug reimbursment
Prostate cancer
+∞
88.2
84
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
87.5
996
5590
A03FA01
ATC
metoclopramide; systemic, rectal
4.3
86.5
359
973
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
86.1
82
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
12.4
83.4
155
135
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
81.6
82.9
93
12
L01AA01
ATC
cyclophosphamide; systemic
87.9
82.8
92
11
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.3
81.3
268
568
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
216.8
81.0
83
*
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
+∞
79.7
76
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
43.0
78.8
98
24
JN4AD
NOMESCO Finland
Body CT examination
7.5
75.7
188
274
399
Kela drug reimbursment
Venetoclax
+∞
75.5
72
*
L01XE27
ATC
[U] ibrutinib; oral
+∞
75.5
72
*
J01MA12
ATC
levofloxacin; systemic
3.1
75.4
491
1902
WF002
NOMESCO Finland
Radical radiotherapy
200.5
74.7
77
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
46.6
72.7
89
20
D70.89
ICD-10 Finland
Neutropenic splenomegaly
21.0
72.6
109
55
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
101.7
71.4
78
8
ZX108
NOMESCO Finland
Inhalation
24.7
70.9
101
43
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
11.1
68.6
134
129
J05AB01
ATC
aciclovir; systemic
3.0
68.3
477
1918
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
670.9
66.3
65
*
2040A
ICD-9 Finland
Lymphoid leukaemia, Acute
+∞
66.0
63
*
1XC02
NOMESCO Finland
NA
35.5
65.7
85
25
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
65.0
62
*
A41.9
ICD-10 Finland
Sepsis, unspecified
6.5
61.6
168
278
ZX112
NOMESCO Finland
Subcutaneous
18.0
60.8
96
56
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.1
60.3
141
186
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
606.6
60.1
59
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
59.7
57
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
59.7
57
*
L01XX52
ATC
venetoclax; oral
+∞
59.7
57
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
59.3
637
3256
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
58.6
56
*
L01EL01
ATC
ibrutinib; oral
+∞
57.6
55
*
PJA12
NOMESCO Finland
Sentinel node biopsy
300.9
57.6
58
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
106.8
57.2
62
6
ZX090
NOMESCO Finland
Other technic of radiotherapy
152.1
56.2
59
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
40.3
55.7
70
18
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
55.5
53
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.5
55.4
111
112
WF049
NOMESCO Finland
Radiotherapy of metastasis
542.8
53.8
53
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
18.3
53.7
84
48
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
+∞
52.3
50
*
ZX131
NOMESCO Finland
Intrathecal
+∞
52.3
50
*
115
Kela drug reimbursment
Breast cancer
+∞
52.3
50
*
212
Kela drug reimbursment
Gout
7.9
51.7
122
163
JN6AD
NOMESCO Finland
CT of torso and neck
39.6
51.6
65
17
127
Kela drug reimbursment
Transplant complication
12.5
51.3
94
79
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
51.3
49
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
51.3
574
2951
1518
Kela drug reimbursment
NA
+∞
50.2
48
*
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
42.6
50.0
62
15
H02AB06
ATC
prednisolone; systemic
2.1
49.5
930
6017
L02AE02
ATC
leuprorelin; implant, parenteral
54.3
48.9
58
11
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
+∞
48.1
46
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
479.3
47.5
47
*
Z51.5
ICD-10 Finland
Palliative care
6.9
46.8
121
185
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
468.8
46.5
46
*
J01MA14
ATC
moxifloxacin; systemic
3.5
46.2
238
751
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.3
46.2
184
465
D70.82
ICD-10 Finland
Drug-induced neutropenia
30.0
45.5
61
21
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
458.3
45.4
45
*
WW200
NOMESCO Finland
Immunization
6.9
45.3
117
179
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
75.0
45.2
51
7
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.4
44.5
140
276
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
426.7
42.3
42
*
A05AA02
ATC
ursodeoxycholic acid; oral
11.6
41.8
79
71
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
41.8
40
*
189
Kela drug reimbursment
Imatinib
+∞
40.8
39
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
405.7
40.2
40
*
N02AA05
ATC
oxycodone; systemic
2.9
39.9
273
1046
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
39.7
38
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
39.3
583
3327
C91
ICD-10 Finland
Lymphoid leukaemia
+∞
38.7
37
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
38.3
425
2129
J02AC03
ATC
voriconazole; systemic
104.7
37.8
41
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
37.6
36
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
37.6
36
*
2041A
ICD-9 Finland
Lymphoid leukaemia, Chronic
+∞
37.6
36
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
37.6
36
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
8.0
37.6
87
113
L57.0
ICD-10 Finland
Actinic keratosis
3.3
37.5
205
673
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.5
37.4
138
323
L02BB03
ATC
bicalutamide; oral
374.3
37.1
37
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.4
36.6
139
334
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
36.6
35
*
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
34.4
36.4
47
14
TQW99
NOMESCO Finland
Other minor procedure on skin
5.0
35.7
119
250
372
Kela drug reimbursment
Idelalisib
+∞
35.5
34
*
1AA09
NOMESCO Finland
NA
+∞
35.5
34
*
ZX121
NOMESCO Finland
Central venous catheter
47.6
34.8
42
9
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
34.5
33
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
343.0
34.0
34
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
34.0
886
6151
B02.9
ICD-10 Finland
Zoster without complication
3.6
33.6
161
477
ZZR00
NOMESCO Finland
Flap of skin
15.7
33.5
55
36
20400
ICD-8 Finland
Lymphatic leukaemia, Acute
+∞
33.4
32
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
33.3
188
630
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.4
32.8
125
302
WF003
NOMESCO Finland
Adjuvant radiotherapy
118.8
32.8
35
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
32.4
31
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
32.4
31
*
L01XX47
ATC
[U] idelalisib; oral
+∞
32.4
31
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.1
31.8
129
330
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
115.3
31.7
34
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.8
31.4
140
390
L01XE01
ATC
[U] imatinib; oral
+∞
31.3
30
*
1XX02
NOMESCO Finland
NA
+∞
31.3
30
*
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
31.3
30
*
A02BC02
ATC
pantoprazole; systemic
1.8
30.9
1103
8370
1CX01
NOMESCO Finland
NA
71.1
30.9
35
5
6BA02
NOMESCO Finland
NA
29.9
30.8
41
14
WW409
NOMESCO Finland
Other aferesis
162.6
30.8
32
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
111.9
30.7
33
*
Z3231
NOMESCO Finland
Registered nurse
1.9
30.7
542
3252
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
9.7
30.7
63
67
L01BC06
ATC
capecitabine; oral
+∞
30.3
29
*
B01AB10
ATC
tinzaparin; parenteral
4.2
30.2
120
301
J02AC01
ATC
fluconazole; systemic
1.9
29.5
571
3532
Z2221
NOMESCO Finland
Medical doctor
1.9
29.4
507
3009
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
29.2
28
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
29.2
28
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
29.2
28
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
105.0
28.7
31
*
Y77
ICPC
Malignant neoplasm prostate
105.0
28.7
31
*
JN4CD
NOMESCO Finland
Very extensive body CT
7.1
28.6
71
103
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
28.2
27
*
9101
FHL
Bone biopsy
65.0
28.0
32
5
TGC00
NOMESCO Finland
Bronchial lavation
5.0
27.2
90
188
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
27.1
26
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.7
27.1
203
814
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
4.0
26.9
111
289
L04AD01
ATC
ciclosporin; systemic
6.9
26.5
67
100
ZX114
NOMESCO Finland
Intramuscular
8.1
26.5
60
76
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
26.1
25
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
26.1
25
*
A04AD12
ATC
aprepitant; systemic
+∞
26.1
25
*
ZXE00
NOMESCO Finland
One hour or less
1.7
26.1
693
4716
B01AB05
ATC
enoxaparin; parenteral
1.9
25.9
500
3062
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.6
25.8
197
799
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
264.0
25.7
26
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.6
25.6
122
359
A04AA55
ATC
palonosetron, combinations; systemic
+∞
25.0
24
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
25.0
24
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
25.0
24
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
58.8
25.0
29
5
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
25.0
439
2596
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
24.7
344
1860
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
131.7
24.6
26
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.8
24.5
164
615
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.5
24.1
63
99
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
24.0
330
1775
C91.2
ICD-10 Finland
Subacute lymphocytic leukemia
+∞
24.0
23
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
24.0
230
1054
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
38.1
24.0
30
8
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
68.3
23.8
27
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
242.8
23.7
24
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
17.4
23.1
36
21
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
84.5
22.7
25
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
6.9
22.7
57
85
A79
ICPC
Malignancy NOS
232.6
22.7
23
*
L03AA10
ATC
lenograstim; parenteral
232.6
22.7
23
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
121.4
22.6
24
*
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
13.8
22.3
38
28
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.0
22.2
91
236
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
52.6
22.1
26
5
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
22.0
613
4176
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.2
21.9
246
1209
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
21.9
21
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
21.9
21
*
153
Kela drug reimbursment
Lenalidomid
+∞
21.9
21
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
222.4
21.6
22
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
222.4
21.6
22
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.9
21.4
89
234
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.8
21.4
147
560
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.6
21.0
162
660
L04AA01
ATC
[U] ciclosporin; systemic
6.6
20.9
54
84
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
20.9
20
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
20.9
20
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
20.9
20
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
20.9
20
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
20.9
20
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
37.6
20.8
26
7
WZC30
NOMESCO Finland
Teaching
2.3
20.3
193
875
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.2
20.3
215
1029
H02AB07
ATC
prednisone; oral
2.0
20.2
275
1465
B74
ICPC
Malignant neoplasm blood other
48.5
20.2
24
5
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
9.5
20.1
41
44
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
17.5
20.0
31
18
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
19.0
20.0
30
16
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
19.8
19
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
19.8
19
*
L02BA01
ATC
tamoxifen; oral
74.3
19.7
22
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
19.7
437
2766
2301
FHL
Lumbar puncture in anesthesia or operating room
201.9
19.6
20
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
19.5
628
4418
J01MA02
ATC
ciprofloxacin; systemic
1.6
19.5
663
4733
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
55.6
18.9
22
*
A02BC01
ATC
omeprazole; systemic
1.7
18.8
511
3427
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
18.8
18
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
18.8
18
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
18.8
18
*
L01BB03
ATC
tioguanine; oral
+∞
18.8
18
*
L04AX04
ATC
lenalidomide; oral
+∞
18.8
18
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
18.8
18
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
18.7
183
841
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
70.6
18.7
21
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
18.7
343
2037
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
23.9
18.6
26
11
B59
ICD-10 Finland
Pneumocystosis
191.7
18.6
19
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
191.7
18.6
19
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
8.5
18.4
40
48
J01DB01
ATC
cefalexin; oral
1.6
18.4
1379
11879
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
20.2
17.7
26
13
J02AC04
ATC
posaconazole; systemic
67.2
17.7
20
*
9670/3-C77.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS
+∞
17.7
17
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
17.7
17
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
17.7
17
*
9831/3-C42.1
ICD-O-3
T-cell large granular lymphocytic leukemia of bone marrow
+∞
17.7
17
*
GD1AD
NOMESCO Finland
Thorax CT examination
3.4
17.7
87
264
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
37.1
17.6
22
6
WW300
NOMESCO Finland
Transfer of autologic stem cells
95.9
17.6
19
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.6
17.6
51
93
ZXC50
NOMESCO Finland
Cryotherapy
4.8
17.5
59
127
A07AA02
ATC
nystatin; oral
2.7
17.5
126
493
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
42.4
17.3
21
5
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.2
17.1
66
163
R4110
NOMESCO Finland
Physiotherapy
1.7
17.0
433
2839
B03XA02
ATC
darbepoetin alfa; parenteral
5.6
16.9
49
89
ZXD05
NOMESCO Finland
Urgent procedure
1.6
16.9
533
3700
150
Kela drug reimbursment
Dasatinib
+∞
16.7
16
*
9823/3-C77.8
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions
+∞
16.7
16
*
9837/3-C42.1
ICD-O-3
Precursor T-cell lymphoblastic leukemia of bone marrow
+∞
16.7
16
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
16.7
16
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
3.7
16.7
73
202
HA1AA
NOMESCO Finland
X-ray mammography
4.5
16.6
59
135
M05BA02
ATC
clodronic acid; systemic
171.4
16.5
17
*
X76
ICPC
Malignant neoplasm breast female
171.4
16.5
17
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
16.5
182
886
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.9
16.2
45
78
Z2446
NOMESCO Finland
Social worker
2.4
16.1
142
619
HAB40
NOMESCO Finland
Wedge excision of mammary gland
13.7
16.0
27
20
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
15.6
15
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
15.6
15
*
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
+∞
15.6
15
*
L01XE06
ATC
[U] dasatinib; systemic
+∞
15.6
15
*
C91.3
ICD-10 Finland
Prolymphocytic leukaemia of B-cell type
+∞
15.6
15
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
15.6
15
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
15.6
15
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.5
15.6
55
125
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
15.6
82
263
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
161.2
15.5
16
*
2AX04
NOMESCO Finland
NA
38.4
15.4
19
5
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
15.0
127
542
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
15.0
467
3215
J01CA04
ATC
amoxicillin; systemic
1.5
14.8
1350
11785
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
9.2
14.7
30
33
9109
FHL
Other measure in this category
21.2
14.7
21
10
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
14.6
483
3373
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
14.6
14
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
14.6
14
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
14.6
14
*
L01XX28
ATC
[D] imatinib; oral
+∞
14.6
14
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
14.6
14
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
14.6
14
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
14.6
14
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
14.6
14
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
14.6
14
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
14.6
14
*
602
Kela drug reimbursment
Children's severe malnutrition
8.9
14.5
30
34
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.1
14.4
28
28
S77
ICPC
Malignant neoplasm of skin
36.3
14.4
18
5
JMA10
NOMESCO Finland
Transabdominal total splenectomy
17.1
14.3
22
13
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
14.3
358
2322
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
8.7
14.2
30
35
ZXC15
NOMESCO Finland
Use of photodynamic technique
8.7
14.2
30
35
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
22.4
14.2
20
9
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
14.2
187
979
UJF32
NOMESCO Finland
Coloscopy
1.6
14.1
407
2740
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.3
14.1
52
124
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
42.8
14.1
17
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
12.0
14.1
25
21
ZXA00
NOMESCO Finland
Right side
1.6
14.0
462
3215
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
30.2
13.9
18
6
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
53.7
13.8
16
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
53.7
13.8
16
*
ZQZ00
NOMESCO Finland
Treatment of several skin areas
23.9
13.8
19
8
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
13.7
642
4844
K03.66
ICD-10 Finland
Tooth plaque
2.3
13.7
132
604
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.5
13.6
64
189
C94.7
ICD-10 Finland
Other specified leukaemias
+∞
13.6
13
*
2AA01
NOMESCO Finland
NA
+∞
13.6
13
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
13.6
13
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
13.6
13
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
13.6
13
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
13.6
13
*
Z92.6
ICD-10 Finland
Personal history of chemotherapy for neoplastic disease
+∞
13.6
13
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
13.6
13
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.0
13.5
53
134
KCD02
NOMESCO Finland
Transurethral resection of bladder
10.1
13.5
26
26
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
5.1
13.2
41
82
B03XA01
ATC
erythropoietin; parenteral
6.4
13.2
34
54
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
13.2
292
1826
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
13.1
611
4594
Z3226
NOMESCO Finland
Physiotherapist
1.7
13.1
315
2017
L04AA06
ATC
mycophenolic acid; systemic
4.4
12.9
46
107
L02BG04
ATC
letrozole; oral
5.9
12.9
35
60
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
5.5
12.8
37
68
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
50.3
12.8
15
*
N02AX02
ATC
tramadol; systemic, rectal
1.5
12.7
668
5143
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
15.5
12.6
20
13
B99
ICPC
Blood/lymph/spleen disease other
12.3
12.6
22
18
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
12.5
12
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
12.5
12
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
12.5
12
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
12.5
12
*
3AA02
NOMESCO Finland
NA
+∞
12.5
12
*
C91.5
ICD-10 Finland
Adult T-cell lymphoma/leukaemia [HTLV-1-associated]
+∞
12.5
12
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
12.5
12
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
12.5
12
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
12.5
12
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
12.5
12
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
130.8
12.4
13
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
130.8
12.4
13
*
C03CA01
ATC
furosemide; systemic
1.5
12.4
572
4283
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.4
12.2
57
169
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
12.1
303
1959
122
Kela drug reimbursment
Aplastic anaemia
26.9
12.0
16
6
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
21.4
12.0
17
8
WX110
NOMESCO Finland
Local anesthesy
1.4
12.0
1045
8829
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.3
11.8
59
184
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.8
11.8
77
285
NK6AN
NOMESCO Finland
Total body bone isotope imaging
14.7
11.8
19
13
A41.8
ICD-10 Finland
Other specified sepsis
4.1
11.7
45
113
306
Kela drug reimbursment
Erythropoietin and darbepoetin
16.5
11.7
18
11
A04AA03
ATC
tropisetron; systemic
65.3
11.6
13
*
L03AB05
ATC
interferon alfa-2b; parenteral
19.0
11.6
17
9
ZZA50
NOMESCO Finland
Full thickness skin graft
23.0
11.6
16
7
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
23.0
11.6
16
7
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
23.0
11.6
16
7
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
8.2
11.6
25
31
HAB99
NOMESCO Finland
Other partial excision of mammary gland
11.2
11.5
21
19
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
11.5
127
618
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
11.5
11
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
11.5
11
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
11.5
11
*
316
Kela drug reimbursment
Imatinib
+∞
11.5
11
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
11.5
11
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
11.5
11
*
E89.4
ICD-10 Finland
Postprocedural ovarian failure
120.7
11.4
12
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
120.7
11.4
12
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
120.7
11.4
12
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
120.7
11.4
12
*
3AA13
NOMESCO Finland
NA
120.7
11.4
12
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
11.4
261
1645
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.9
11.4
70
250
WX402
NOMESCO Finland
General anaesthesia
1.8
11.3
210
1241
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.6
11.2
82
327
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
20.1
11.1
16
8
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
11.1
276
1778
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.9
11.0
35
73
FM2CE
NOMESCO Finland
NA
4.7
10.9
36
78
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
10.9
148
787
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.9
10.8
43
112
DHB00
NOMESCO Finland
Excision of lesion of external nose
10.6
10.8
20
19
5BA08
NOMESCO Finland
NA
8.9
10.8
22
25
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
9.6
10.7
21
22
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
60.3
10.6
12
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
7.0
10.6
25
36
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.3
10.5
96
431
B01.9
ICD-10 Finland
Varicella without complication
7.3
10.5
24
33
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
6.2
10.4
27
44
ZXC20
NOMESCO Finland
Use of chemical agents
4.7
10.4
34
73
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
110.6
10.4
11
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
110.6
10.4
11
*
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
110.6
10.4
11
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
110.6
10.4
11
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
10.4
10
*
B72
ICPC
Hodgkin Lymphoma
+∞
10.4
10
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
10.4
10
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
10.4
10
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
10.4
10
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
10.4
10
*
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
10.4
10
*
WW402
NOMESCO Finland
Leucoferesis
+∞
10.4
10
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
10.4
10
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
10.4
10
*
C95.1
ICD-10 Finland
Chronic leukaemia of unspecified cell type
+∞
10.4
10
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
10.4
10
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
10.4
10
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
10.4
10
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
10.4
10
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
10.4
10
*
4CJ01
NOMESCO Finland
NA
+∞
10.4
10
*
L01AA03
ATC
melphalan; systemic
+∞
10.4
10
*
2024A
ICD-9 Finland
Other malignant neoplasm of lymphoid and histiocytic tissue, Leukaemic reticuloendotheliosis
+∞
10.4
10
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
10.4
10
*
XQ848
NOMESCO Finland
Dermatological photography
3.8
10.4
42
111
D06BB10
ATC
imiquimod; topical
2.6
10.4
73
285
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
12.1
10.3
18
15
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.0
10.3
32
65
GDC00
NOMESCO Finland
Lobectomy of lung
32.7
10.3
13
*
A06AD11
ATC
lactulose; oral
1.6
10.3
261
1688
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
9.6
10.2
20
21
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
23.5
10.2
14
6
R4190
NOMESCO Finland
Nutritional therapy
2.9
10.1
60
212
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
10.0
111
542
0388X
ICD-9 Finland
Septicaemia, Other specified septicaemias
16.8
9.9
15
9
120
Kela drug reimbursment
Hypogammaglobulinaemia
26.1
9.8
13
5
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
5.7
9.8
27
48
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
3.8
9.8
40
107
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
20.1
9.8
14
7
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.8
9.7
59
212
M87.3
ICD-10 Finland
Other secondary osteonecrosis
55.2
9.6
11
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
9.5
565
4393
TPX15
NOMESCO Finland
Removal of vascular injection port
15.1
9.5
15
10
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.3
9.5
34
81
S18
ICPC
Laceration/cut
1.4
9.5
650
5190
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
100.5
9.4
10
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
100.5
9.4
10
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
9.4
9
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
9.4
9
*
C44.20
ICD-10 Finland
Malignant tumor of the skin of the outer ear and of the outer ear canal without histology
+∞
9.4
9
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
9.4
9
*
9800/3-C42.1
ICD-O-3
Leukemia, NOS, of bone marrow
+∞
9.4
9
*
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
9.4
9
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
9.4
9
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
9.4
9
*
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
9.4
9
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
329
Kela drug reimbursment
Lenalidomide
+∞
9.4
9
*
1XX32
NOMESCO Finland
NA
+∞
9.4
9
*
L01EA02
ATC
dasatinib; oral
+∞
9.4
9
*
B84
ICPC
Unexplained abnormal white cells
+∞
9.4
9
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
9.4
9
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
9.4
9
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
9.4
9
*
Z31.6
ICD-10 Finland
General counselling and advice on procreation
8.7
9.3
19
22
ZYC01
NOMESCO Finland
Remote contact by phone
2.4
9.3
76
323
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
11.5
9.1
16
14
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
15.6
9.0
14
9
ZXA05
NOMESCO Finland
Left side
1.5
9.0
412
3046
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.3
9.0
43
132
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
18.7
8.9
13
7
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.4
8.9
74
317
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
12.6
8.9
15
12
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
4.8
8.9
28
59
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.1
8.8
33
82
E83.50
ICD-10 Finland
Hypercalcemia
5.6
8.7
24
43
B34.9
ICD-10 Finland
Viral infection, unspecified
2.8
8.7
55
201
RS221
NOMESCO Finland
NA
3.8
8.7
35
93
A01AB09
ATC
miconazole; local oral
1.8
8.7
153
890
5639
FHL
Other measure in this category
50.2
8.7
10
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.1
8.7
32
79
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
8.6
318
2245
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.2
8.6
22
36
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
4.6
8.6
28
61
J12.8
ICD-10 Finland
Other viral pneumonia
5.8
8.6
23
40
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
9.0
8.5
17
19
N02BE01
ATC
paracetamol; systemic, rectal
1.4
8.5
1390
12659
P01AB01
ATC
metronidazole; oral, rectal
1.4
8.5
535
4189
J20.6
ICD-10 Finland
Acute bronchitis due to rhinovirus
27.6
8.5
11
*
L03AA04
ATC
NA
27.6
8.5
11
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
20.1
8.5
12
6
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.1
8.5
31
76
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
3.3
8.4
40
122
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
90.4
8.4
9
*
K00.29
ICD-10 Finland
Other or indefinite deviation in the shape or size of the teeth
90.4
8.4
9
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
90.4
8.4
9
*
L02AE04
ATC
triptorelin; parenteral
90.4
8.4
9
*
DAB10
NOMESCO Finland
Partial excision of auricle
90.4
8.4
9
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
12.8
8.4
14
11
1XC15
NOMESCO Finland
NA
+∞
8.3
8
*
393
Kela drug reimbursment
Pomalidomide
+∞
8.3
8
*
9801/3-C42.1
ICD-O-3
Acute leukemia, NOS, of bone marrow
+∞
8.3
8
*
L02BX02
ATC
degarelix; parenteral
+∞
8.3
8
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
8.3
8
*
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
8.3
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
8.3
8
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
8.3
8
*
324
Kela drug reimbursment
Dasatinib
+∞
8.3
8
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
8.3
8
*
C44.40
ICD-10 Finland
Malignant tumor of the skin of the scalp and neck without histology
+∞
8.3
8
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.3
8
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
8.3
8
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
8.3
8
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
8.3
8
*
152
Kela drug reimbursment
Nilotinib
+∞
8.3
8
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
8.3
8
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
8.3
8
*
J01FF01
ATC
clindamycin; systemic
1.4
8.3
407
3046
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
5.3
8.3
24
46
JFB30
NOMESCO Finland
Right hemicolectomy
8.6
8.3
17
20
ZXE20
NOMESCO Finland
More than three and less than five hours
1.6
8.3
198
1262
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.0
8.2
44
147
K02.0
ICD-10 Finland
Caries limited to enamel
1.7
8.2
183
1144
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.6
8.2
35
99
H65.2
ICD-10 Finland
Chronic serous otitis media
4.0
8.1
31
79
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
33.5
8.1
10
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.0
8.1
30
75
J35.1
ICD-10 Finland
Hypertrophy of tonsils
3.9
8.0
31
80
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
10.1
8.0
15
15
SPAT1153
SPAT
Removal of sutures
1.4
8.0
468
3611
DAB00
NOMESCO Finland
Excision of lesion of auricle
7.3
8.0
18
25
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.7
7.9
54
207
ZXC96
NOMESCO Finland
Robot assisted procedure
7.8
7.9
17
22
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.9
7.9
112
606
L01XX05
ATC
hydroxycarbamide; oral
3.6
7.9
33
92
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
7.9
279
1952
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
8.5
7.8
16
19
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.3
7.8
69
305
K12.10
ICD-10 Finland
Stomatitis NOS
7.0
7.8
18
26
J94.8
ICD-10 Finland
Other specified pleural conditions
3.8
7.7
31
83
XX1AD
NOMESCO Finland
Other CT-examination
45.1
7.7
9
*
B02
ICD-10 Finland
Zoster [herpes zoster]
2.5
7.7
57
231
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
15.1
7.7
12
8
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.1
7.7
81
389
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.0
7.7
90
452
TKE00
NOMESCO Finland
Needle biopsy of prostate
2.6
7.6
53
208
ZX100
NOMESCO Finland
Oral
4.2
7.6
27
65
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
11.9
7.6
13
11
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
25.1
7.6
10
*
EBA10
NOMESCO Finland
Surgical removal of tooth
1.7
7.6
151
914
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
4.7
7.5
24
52
ZZA00
NOMESCO Finland
Split skin graft
2.9
7.5
43
150
B07.9
ICD-10 Finland
Verruca simplex
2.5
7.4
53
212
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
80.4
7.4
8
*
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.6
7.4
31
87
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.7
7.4
30
82
TQW80
NOMESCO Finland
Local dermatologic skincare
2.8
7.4
45
165
ED1AA
NOMESCO Finland
Mandipular X-ray examination
8.4
7.3
15
18
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
7.3
81
399
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.9
7.3
108
595
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
7.3
7
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
7.3
7
*
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
+∞
7.3
7
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
+∞
7.3
7
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
7.3
7
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
7.3
7
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
7.3
7
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
7.3
7
*
9836/3-C42.1
ICD-O-3
Precursor B-cell lymphoblastic leukemia of bone marrow
+∞
7.3
7
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
7.3
7
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
7.3
7
*
5609
FHL
Other measure in this category
+∞
7.3
7
*
L01CA04
ATC
vinorelbine; systemic
+∞
7.3
7
*
KFC10
NOMESCO Finland
Bilateral orchiectomy
+∞
7.3
7
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.4
7.2
60
258
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
15.8
7.2
11
7
IEP04
NOMESCO Finland
Focused parenting intervention
15.8
7.2
11
7
JFF23
NOMESCO Finland
Transversostomy
15.8
7.2
11
7
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
3.7
7.2
29
79
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
30.1
7.1
9
*
0539X
ICD-9 Finland
Herpes zoster without mention of complication
20.1
7.1
10
5
ZY010
NOMESCO Finland
Hospital outpatient
2.2
7.1
67
306
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.2
7.1
34
106
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.8
7.1
43
157
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.8
7.1
28
75
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.2
7.0
65
297
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.4
7.0
32
96
XKD00
NOMESCO Finland
Uroflowmetry
1.5
7.0
261
1846
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
6.9
153
955
L91.0
ICD-10 Finland
Hypertrophic scar
5.5
6.9
19
35
SPAT1088
SPAT
Blood transfusion
7.5
6.9
15
20
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.7
6.9
28
77
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
11.0
6.8
12
11
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
9.3
6.8
13
14
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
9.3
6.8
13
14
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
16.7
6.7
10
6
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
16.7
6.7
10
6
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
22.6
6.7
9
*
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
22.6
6.7
9
*
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
3.7
6.7
27
74
N05CF01
ATC
zopiclone; oral
1.3
6.7
484
3854
QBA10
NOMESCO Finland
Incision of skin of trunk
5.2
6.6
19
37
5604
FHL
Vascular preparation or cannulation in the operating room
8.7
6.5
13
15
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
8.7
6.5
13
15
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
6.5
98
544
R06AE07
ATC
cetirizine; oral
1.3
6.5
587
4824
N03AX16
ATC
pregabalin; oral
1.4
6.5
319
2379
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
5.0
6.5
19
38
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
5.0
6.5
19
38
R05
ICD-10 Finland
Cough
1.4
6.5
290
2127
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
5.3
6.5
18
34
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
6.4
254
1818
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
70.0
6.4
7
*
A21
ICPC
Risk factor for malignancy
70.0
6.4
7
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
70.0
6.4
7
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.4
6.4
49
204
WX892
NOMESCO Finland
Monitored bed care
1.7
6.4
127
770
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
14.3
6.4
10
7
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
3.8
6.4
25
67
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
6.6
6.3
15
23
R11
ICD-10 Finland
Nausea and vomiting
1.8
6.3
112
654
B02
ICPC
Lymph gland(s) enlarged/painful
5.2
6.3
18
35
TQW40
NOMESCO Finland
Remowal of suture of skin
1.9
6.3
88
476
EMA10
NOMESCO Finland
Biopsy of tonsil
11.0
6.3
11
10
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.9
6.3
82
433
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
9.3
6.3
12
13
6753
FHL
Transabdominal splenectomy
18.1
6.3
9
5
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
6.3
6
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
6.3
6
*
YNB20
NOMESCO Finland
Storage of stem cells for transplant
+∞
6.3
6
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
6.3
6
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
6.3
6
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
6.3
6
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
6.3
6
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
6.3
6
*
9670/3-C77.3
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm
+∞
6.3
6
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
6.3
6
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
6.3
6
*
9670/3-C77.0
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck
+∞
6.3
6
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
6.3
6
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
6.3
6
*
L01EM01
ATC
idelalisib; oral
+∞
6.3
6
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
+∞
6.3
6
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
6.3
6
*
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
+∞
6.3
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.3
6
*
L04AX06
ATC
pomalidomide; oral
+∞
6.3
6
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
6.3
6
*
1507
Kela drug reimbursment
Pomalidomide
+∞
6.3
6
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
6.3
6
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
6.3
6
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
6.3
6
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.3
6
*
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
6.3
6
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
6.3
6
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
6.3
6
*
TQW20
NOMESCO Finland
Tatoe
+∞
6.3
6
*
NEA20
NOMESCO Finland
Exploration of soft tissue of pelvis,v
26.7
6.2
8
*
R50.8
ICD-10 Finland
Other specified fever
7.0
6.2
14
20
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
7.0
6.2
14
20
UDC00
NOMESCO Finland
Ear microscopy
1.7
6.2
113
668
ZXD00
NOMESCO Finland
Emergency procedure
2.2
6.2
56
253
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.0
6.2
73
372
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.8
6.1
93
519
A03
ICPC
Fever
1.5
6.1
213
1482
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.5
6.1
26
75
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
12.6
6.1
10
8
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
12.6
6.1
10
8
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.3
6.1
55
248
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
4.9
6.0
18
37

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022096) Basophils/100 leukocytes in Blood
1576
6908
6.62
323.31
19.2
5.7
%
0.5
0.7
45.92
1530
6369
(3002030) Lymphocytes/100 leukocytes in Blood
1618
7301
6.87
319.64
20.6
5.8
%
50.8
27.6
220.57
1571
6712
(3025159) Blasts/100 leukocytes in Blood
577
1070
7.12
315.18
10.6
3.9
%
0.0
0.4
0.43
421
217
(42870588) Differential panel, method unspecified - Blood
1378
5242
6.01
307.65
20.5
5.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
1613
7111
7.05
307.65
19.9
5.7
%
1.8
3.0
114.33
1571
6538
(3017181) Myelocytes/100 leukocytes in Blood
717
1169
8.91
307.65
10.7
3.8
%
0.2
0.8
12.03
518
275
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
603
383
21.92
307.65
2.7
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
508
782
8.32
307.65
3.0
1.7
g/l
1.2
1.5
5.90
442
667
(3045142) Bone marrow Pathology biopsy report
362
114
38.38
307.65
1.5
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
222
80
31.01
307.65
2.6
2.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
417
181
28.69
307.65
7.3
3.0
%
0.3
1.5
3.06
338
131
(3027945) Reticulocytes/100 erythrocytes in Blood
1079
2092
9.82
307.65
8.1
2.4
%
1.7
1.7
0.16
1027
1822
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
279
184
17.40
307.65
3.7
4.5
u/ml
2216.3
338.7
0.46
25
18
(3042111) Morphology [Interpretation] in Bone marrow Narrative
421
218
24.07
307.65
2.4
1.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
247
80
34.98
307.65
2.8
2.4
%
26.8
53.9
—
23
7
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
346
239
17.23
307.65
6.9
6.2
iu/ml
514.0
434.3
0.13
61
28
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1279
1631
19.32
307.65
14.7
2.8
u/l
239.6
235.9
0.27
1242
1519
(3002179) Metamyelocytes/100 leukocytes in Blood
626
1076
7.95
307.65
10.7
3.7
%
0.1
0.6
5.87
401
201
(3023520) Reticulocytes [#/volume] in Blood
930
1564
10.09
307.65
8.5
2.4
e9/l
68.4
67.8
0.15
734
1200
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
222
80
31.01
307.65
2.6
2.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
543
826
8.59
307.65
2.3
1.4
g/l
1.1
1.1
0.10
485
753
(3021440) Promyelocytes/100 leukocytes in Blood
640
1122
7.85
307.65
11.3
3.9
%
0.0
0.1
0.38
498
250
(3000093) Morphology [Interpretation] in Blood Narrative
270
166
18.59
307.65
1.1
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
872
1032
14.00
307.65
4.8
2.2
g/l
8.2
10.7
30.89
836
944
(3019069) Monocytes/100 leukocytes in Blood
1614
7143
7.02
307.65
21.2
6.0
%
6.6
8.8
76.24
1568
6598
(4035726)
420
459
11.26
307.65
1.6
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
244
145
18.97
299.39
10.9
3.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
230
128
20.12
290.93
7.7
2.8
%
30.9
58.4
16.97
128
80
(3018010) Neutrophils/100 leukocytes in Blood
1563
7221
5.97
288.35
18.3
5.7
%
38.3
57.3
206.17
1512
6673
(3011412) CD3 cells [#/volume] in Blood
208
96
24.01
285.06
3.8
2.3
e9/l
1.4
1.2
0.48
125
58
(21494434) Karyotype in Bone marrow
225
133
18.89
276.42
1.2
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
185
78
25.98
262.30
3.6
1.8
e6/l
561.2
854.0
1.56
62
24
(3001604) Monocytes [#/volume] in Blood
1544
7572
5.27
249.46
17.1
5.5
e9/l
0.7
0.6
1.89
1395
6412
(3006315) Basophils [#/volume] in Blood
1549
7621
5.28
249.07
17.1
5.5
e9/l
0.1
0.0
0.98
1400
6466
(3021879) Hepatitis B virus core Ab [Presence] in Serum
445
804
6.80
245.56
1.3
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1570
7871
5.31
244.48
20.5
5.6
e9/l
0.2
0.2
19.03
1440
6769
(3019198) Lymphocytes [#/volume] in Blood
1555
7767
5.21
242.49
17.6
5.5
e9/l
10.4
1.9
48.27
1449
6701
(3026493) Urate [Moles/volume] in Serum or Plasma
1089
4191
4.43
242.47
8.9
2.6
umol/l
1009.8
7049.8
9.27
1028
3552
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
168
69
26.44
240.27
2.4
2.4
%
27.4
42.4
4.14
38
29
(3013650) Neutrophils [#/volume] in Blood by Automated count
1609
8417
5.31
231.60
30.5
6.3
e9/l
3.5
4.4
28.81
1519
7166
(1175426) CD3 cells/100 lymphocytes in Blood
170
80
23.09
230.53
2.9
2.5
%
61.3
67.8
1.32
165
75
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
167
78
23.23
227.12
2.9
2.5
%
9.8
12.5
0.80
71
51
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
261
286
10.32
220.28
1.2
1.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1464
7410
4.45
212.71
16.0
4.0
umol/l
11.4
13.0
6.92
1435
6913
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
156
77
21.85
207.14
3.1
2.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
250
288
9.75
202.88
1.2
1.5
—
14.9
—
0
7
(3020630) Protein [Mass/volume] in Serum or Plasma
523
1332
4.93
194.87
3.3
1.6
g/l
64.4
66.6
5.93
495
1189
(40768795) Lymph node Pathology biopsy report
117
30
41.30
192.92
1.2
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
524
1362
4.83
190.02
1.4
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
110
25
46.44
186.63
1.2
1.0
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
144
81
19.05
180.12
4.5
2.0
e6/l
751.1
483.9
2.68
120
66
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
142
78
19.49
179.58
4.6
2.0
e9/l
0.3
0.2
0.47
122
66
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
221
256
9.56
178.11
1.3
1.6
u/ml
98.2
102.7
0.22
36
38
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
569
1659
4.37
176.84
1.5
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
816
3078
3.75
175.36
13.6
4.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
244
329
8.29
173.92
3.2
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
246
339
8.11
172.08
3.0
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
119
48
26.26
170.72
6.4
3.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
158
119
14.31
169.66
2.3
2.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
154
114
14.53
166.98
1.1
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
92
15
64.17
166.50
1.3
1.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
97
26
39.11
157.86
1.3
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
201
242
9.10
156.83
3.3
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
438
1140
4.62
156.34
2.9
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
640
2204
3.77
155.01
11.3
5.8
mmol/l
1.1
1.1
0.81
607
2028
(21494814) CD8 cells/100 lymphocytes in Specimen
93
25
38.92
151.17
1.8
2.8
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
143
0
+∞
150.93
1.2
0.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
214
295
7.99
149.19
1.2
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
592
2041
3.68
141.64
1.5
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
126
93
14.37
136.56
3.1
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
941
4386
3.12
136.05
8.1
4.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
249
449
6.18
134.50
1.3
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
125
95
13.95
133.18
1.4
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
196
280
7.64
132.15
1.3
1.5
u/ml
248.1
236.3
0.16
105
149
(3037756) Immunofixation for Serum or Plasma
201
310
7.08
126.31
1.5
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1355
7965
3.09
125.43
15.0
6.1
mmol/l
1.2
1.2
0.01
1177
6716
(3012095) Magnesium [Moles/volume] in Serum or Plasma
612
2315
3.35
124.59
6.7
3.2
mmol/l
0.8
0.8
0.00
581
2117
(3021589) Normoblasts [#/volume] in Blood
1212
6793
2.93
120.80
26.8
8.8
e9/l
0.0
0.0
1.02
1056
5465
(3008536) Aspergillus sp Ab [Presence] in Serum
72
17
43.86
120.62
2.6
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
283
641
4.96
118.29
2.7
1.4
g/l
3.1
3.9
8.51
220
464
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
283
642
4.96
118.06
2.7
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
283
642
4.96
118.06
2.7
1.4
g/l
6.8
7.4
4.98
223
474
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
64
11
60.02
114.37
1.2
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
673
2828
3.06
112.98
2.2
1.3
g/l
1.6
2.6
20.17
556
1578
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
252
538
5.20
112.72
3.0
1.5
g/l
1.1
0.5
1.97
226
457
(3048879) Bone marrow aspiration report
82
37
23.04
112.33
2.3
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
266
597
4.97
112.20
2.7
1.4
g/l
3.0
3.1
0.18
221
471
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
171
257
7.17
109.80
6.0
3.4
%
36.6
57.5
27.09
171
257
(40758558) Short blood count panel - Blood
778
3593
2.88
109.27
25.3
4.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
456
1546
3.51
109.20
6.5
2.8
umol/l
7.3
8.5
0.47
413
1329
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
265
607
4.87
108.98
2.7
1.4
g/l
8.7
10.4
5.77
234
510
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
218
423
5.65
108.40
8.2
3.1
g/l
3.5
3.4
0.46
207
398
(3018418) pH of Serum or Plasma
897
4500
2.77
106.97
9.4
3.3
ph
7.4
7.4
0.07
158
784
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
68
21
33.46
106.04
1.9
3.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
152
209
7.78
105.61
2.2
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1223
7224
2.73
104.44
13.7
5.8
mmol/l
1.2
1.2
0.14
1153
6407
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
229
482
5.22
103.89
2.8
1.5
g/l
0.0
0.0
0.51
217
437
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
164
251
7.02
103.45
1.6
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
123
137
9.49
101.34
3.7
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1132
6515
2.66
100.58
8.5
4.1
g/l
34.9
35.4
1.50
1072
5968
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
631
2735
2.89
98.08
3.2
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
128
157
8.63
97.78
3.7
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
66
25
27.24
96.35
5.1
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
129
165
8.28
95.19
2.3
1.6
—
—
—
0
0
(44806118)
133
177
7.97
94.93
2.4
1.6
—
—
—
0
0
(44790048)
133
177
7.97
94.93
2.4
1.6
—
—
—
0
0
(44790049)
133
177
7.97
94.93
2.4
1.6
—
—
—
0
0
(44790047)
133
177
7.97
94.93
2.4
1.6
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
213
455
5.11
94.78
2.9
1.4
g/l
0.0
0.0
0.00
202
411
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
210
445
5.14
94.31
2.9
1.4
g/l
0.0
0.0
0.00
202
409
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1635
11574
3.07
92.23
19.1
5.4
u/l
83.2
79.9
2.03
1597
10669
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
138
199
7.36
91.78
1.5
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
225
519
4.75
91.26
2.8
1.4
g/l
38.6
37.7
1.25
210
434
(40768804) Tissue Pathology biopsy report
859
4534
2.54
88.31
2.8
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
217
514
4.60
85.02
3.4
2.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
482
1935
2.95
84.84
2.7
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
480
1938
2.93
83.48
2.5
1.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
71
45
16.31
83.22
1.3
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
508
2161
2.80
79.73
2.9
2.7
%
24.4
22.7
1.58
451
1823
(3004789) Transferrin [Mass/volume] in Serum or Plasma
525
2322
2.70
75.95
2.8
2.6
g/l
2.2
2.3
2.39
497
2138
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
96
115
8.71
74.57
4.1
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
96
115
8.71
74.57
4.1
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
96
115
8.71
74.57
4.1
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
65
43
15.58
74.45
4.5
2.5
e6/l
6920.2
355.0
1.24
44
26
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
146
288
5.38
70.76
1.3
1.2
u/l
110.7
21.5
2.33
133
249
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
127
221
6.06
70.35
1.7
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
542
2525
2.56
69.79
2.9
2.6
umol/l
13.5
13.0
0.82
516
2312
(3044640) Blood type and Crossmatch panel - Blood
793
4387
2.32
69.51
6.7
2.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
191
486
4.23
67.87
3.7
1.5
ratio
2.2
2.6
—
9
43
(3002256) Pathology report gross observation
312
1101
3.16
67.81
1.6
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
193
502
4.14
66.56
3.8
1.5
mg/l
37.4
46.3
0.32
171
404
(3034860) Kappa light chains.free [Mass/volume] in Serum
193
503
4.13
66.38
3.8
1.5
mg/l
65.8
47.3
1.32
169
404
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
114
190
6.29
65.92
1.7
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
167
397
4.49
64.77
1.2
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
536
2566
2.48
64.46
5.4
2.2
s
29.8
30.1
0.58
519
2482
(3033658) Prothrombin time (PT) actual/Normal
685
3657
2.31
64.30
10.2
3.9
%
86.2
83.7
1.81
673
3553
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
222
661
3.65
63.09
2.3
1.7
ug/l
1.9
1.8
0.03
199
570
(40760888) Immunoglobulin light chains.free panel - Serum
158
372
4.52
61.99
3.9
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
135
280
5.09
61.72
1.5
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
62
53
12.03
61.15
5.3
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
62
53
12.03
61.15
5.3
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
62
53
12.03
61.15
5.3
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
62
53
12.03
61.15
5.3
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
54
37
14.96
60.61
5.9
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
54
37
14.96
60.61
5.9
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
54
37
14.96
60.61
5.9
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
115
214
5.63
59.30
1.2
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
292
1077
3.00
58.33
2.4
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1325
9431
2.15
57.63
9.1
4.7
mmol/l
6.7
6.9
1.64
1278
8790
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
114
219
5.45
56.77
1.2
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
55
44
12.82
56.48
1.0
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
171
461
3.96
55.95
16.7
6.5
mg/l
1.2
1.5
4.70
158
412
(3015377) Calcium [Moles/volume] in Serum or Plasma
815
4883
2.11
55.60
4.6
2.1
mmol/l
2.3
2.4
1.84
725
4031
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
627
3416
2.21
54.42
5.8
2.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
356
1516
2.63
53.86
11.2
7.1
mmol/l
9.4
10.5
2.06
335
1434
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1011
6659
2.03
52.30
8.9
3.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
167
469
3.79
51.49
1.7
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
57
57
10.26
50.58
1.6
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
80
124
6.67
49.56
1.7
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
787
4816
2.03
49.24
4.0
3.2
e6/l
53.5
85.8
1.00
638
3698
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
84
138
6.30
49.19
3.2
2.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
50
43
11.89
49.06
1.2
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
58
62
9.60
49.05
1.5
1.1
—
—
—
0
0
(3036489) Thrombin time
175
524
3.56
49.02
8.9
2.5
s
23.5
21.5
2.30
169
467
(3030467) Casts [#/volume] in Urine by Automated count
731
4388
2.04
47.98
3.9
3.2
e6/l
0.4
0.4
0.35
585
3313
(3017732) Neutrophils [#/volume] in Blood
259
991
2.85
47.96
4.0
3.0
e9/l
3.8
4.2
1.50
194
718
(3001122) Ferritin [Mass/volume] in Serum or Plasma
961
6353
1.97
47.79
4.0
2.9
ug/l
330.7
133.1
2.50
900
5787
(3013707) Erythrocyte sedimentation rate by Westergren method
1496
11544
2.11
47.43
6.1
4.1
mm/h
14.0
12.3
3.14
1421
10571
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
69
99
7.18
45.89
1.2
1.4
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
68
98
7.14
45.04
3.0
3.3
mu/l
13.2
30.6
1.31
68
89
(3026782) Osmolality of Urine
562
3132
2.10
44.59
3.2
2.7
mosm/kgh2o
551.6
557.4
0.28
497
2623
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
220
804
2.95
44.20
3.2
1.4
ug/l
6.5
3.4
0.61
161
607
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
38
25
15.47
43.46
1.8
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
36
22
16.64
42.73
1.1
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
43
38
11.54
41.42
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
126
339
3.89
41.19
2.6
1.6
u/l
8.3
7.2
0.52
95
271
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
108
261
4.31
40.82
1.1
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
423
2177
2.19
40.81
2.3
2.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
850
5604
1.89
40.66
4.6
3.7
e6/l
170.0
105.7
0.38
672
3958
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
693
4278
1.94
40.50
2.6
2.4
mg/l
3.7
2.9
7.86
616
3609
(3000850) Epithelial cells [#/volume] in Urine
578
3365
2.00
39.99
3.1
2.5
e6/l
5.0
5.1
0.10
512
2918
(36304419) Bacteria [Presence] in Urine
687
4249
1.93
39.78
3.9
3.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
552
3171
2.02
39.60
4.2
1.8
mg/l
1.4
1.3
0.32
447
2430
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
133
382
3.65
39.55
1.8
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
133
382
3.65
39.55
1.8
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
88
186
4.90
39.25
1.6
1.5
g/l
31.5
27.8
1.61
80
166
(40758292) HTLV I+II Ab panel - Serum
45
7
65.64
39.20
1.2
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
31
17
18.50
38.69
1.7
4.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
351
1708
2.27
38.68
2.0
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
42
40
10.70
38.49
2.0
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
115
306
3.92
38.16
9.0
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
710
4504
1.88
37.59
6.6
2.7
u/l
33.7
38.5
0.61
686
4251
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
36
28
13.07
37.48
1.2
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
34
24
14.39
37.39
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
39
35
11.34
37.17
1.2
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
27
12
22.78
36.76
1.3
2.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
360
1836
2.17
35.08
1.9
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
84
190
4.57
34.51
3.0
3.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
102
270
3.92
34.08
2.8
1.5
iu/l
12.8
18.4
1.49
81
217
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
239
1036
2.48
34.01
2.1
1.7
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
65
121
5.51
33.44
1.4
1.3
u/l
286.2
310.6
0.17
59
116
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
116
347
3.48
32.40
8.9
1.3
e6/l
891.6
635.5
0.12
97
293
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
116
347
3.48
32.40
8.9
1.3
e6/l
7.9
30.9
0.74
95
281
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
54
89
6.20
31.50
2.0
1.2
ug/l
4.3
3.4
0.22
45
79
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
47
67
7.16
31.42
3.2
2.3
u/ml
5169.3
1074.4
2.28
47
67
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
50
77
6.63
31.14
3.1
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
928
6666
1.72
30.54
11.5
10.9
inr
1.3
1.4
1.76
271
1857
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
27
18
15.19
30.54
4.9
5.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
69
147
4.82
30.49
7.9
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
79
190
4.28
30.03
1.3
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
73
167
4.50
29.58
1.7
1.5
e6/l
5210.9
1971.9
0.77
60
118
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
40
51
7.98
29.42
2.6
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
112
349
3.34
29.33
8.2
1.2
mmol/l
3.4
3.9
6.00
107
323
(3023410) Appearance of Cerebral spinal fluid
70
156
4.61
29.30
12.9
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
52
89
5.97
29.21
1.5
1.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
81
204
4.09
28.98
6.5
6.9
mg/l
10.8
12.2
1.68
67
185
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
55
101
5.57
28.72
1.8
1.5
nmol/l
0.2
0.3
0.84
47
83
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
431
2505
1.91
28.69
3.6
3.0
e6/l
2.4
2.1
0.30
266
1379
(3000991) Gas panel - Venous blood
294
1497
2.13
28.36
12.7
7.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1291
10253
1.70
28.34
5.4
4.5
e6/l
521.0
2139.6
1.13
25
164
(3028308) Erythrocytes [#/volume] in Pleural fluid
67
154
4.46
26.99
1.7
1.5
e6/l
71352.0
72760.3
0.01
47
93
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
47
79
6.07
26.89
1.5
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
449
2695
1.85
26.84
3.5
2.8
e6/l
1.1
1.3
0.48
284
1561
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
58
120
4.94
26.53
1.2
1.0
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
35
43
8.26
26.53
1.1
1.7
iu/ml
—
1903858.3
—
0
6
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
22
13
17.09
26.36
1.7
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
357
2001
1.95
26.27
12.5
6.1
mmol/l
104.6
104.3
0.66
350
1943
(3036481) Cortisol [Moles/volume] in Serum or Plasma
270
1371
2.12
26.13
2.5
1.9
nmol/l
394.1
361.4
1.86
258
1238
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
759
5350
1.67
25.49
3.2
3.2
ng/l
1985.0
1687.3
0.93
674
4594
(3012441) Differential panel - Pleural fluid
62
142
4.47
25.10
1.5
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
685
4720
1.68
24.99
3.3
2.3
u/l
55.1
59.5
1.00
637
4314
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
45
78
5.88
24.96
1.5
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
615
4121
1.70
24.90
1.8
1.5
nmol/l
19.4
20.2
0.62
560
3430
(3024139) IgG subclass 3 [Mass/volume] in Serum
61
139
4.49
24.85
1.4
1.3
g/l
0.3
0.4
0.60
47
101
(3027135) IgG subclass 1 [Mass/volume] in Serum
61
139
4.49
24.85
1.4
1.3
g/l
6.4
6.8
0.22
52
102
(3028192) IgG subclass 2 [Mass/volume] in Serum
61
139
4.49
24.85
1.4
1.3
g/l
1.8
2.9
4.74
52
102
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
120
433
2.88
24.46
1.8
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
249
1258
2.12
24.34
2.3
2.4
g/l
0.2
0.2
0.17
225
1140
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
19
10
19.17
23.94
9.6
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
111
389
2.96
23.84
1.5
1.2
—
—
—
0
0
(4062490)
60
140
4.38
23.74
1.4
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
56
124
4.61
23.64
1.7
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
53
113
4.79
23.42
1.7
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
319
1787
1.93
23.32
13.2
4.0
mmol/l
1.9
1.8
0.07
268
1428
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
46
87
5.39
23.28
2.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
46
89
5.26
22.71
2.3
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
24
22
11.03
22.46
1.5
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
206
999
2.18
22.30
1.6
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
39
66
6.00
22.17
2.5
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
39
66
6.00
22.17
2.5
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
22
18
12.34
22.09
1.5
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
22
18
12.34
22.09
1.5
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
22
18
12.34
22.09
1.5
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
316
1800
1.89
21.87
13.3
4.0
kpa
5.7
5.8
1.87
308
1740
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
437
2755
1.75
21.62
4.2
2.2
mmol/l
2.5
2.4
0.42
391
2342
(3052851) Hemolysis interference index of Serum or Plasma
118
451
2.72
21.58
5.8
3.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
131
535
2.55
20.97
4.4
4.2
u/ml
0.3
0.3
0.62
82
322
(3012544) pH of Venous blood
322
1869
1.86
20.96
13.1
4.1
ph
7.4
7.4
—
5
11
(3020393) Adenovirus Ag [Presence] in Stool
28
35
8.10
20.91
2.1
2.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
237
1254
2.01
20.31
3.3
2.2
u/l
31.1
39.2
1.22
213
1038
(3014111) Lactate [Moles/volume] in Serum or Plasma
263
1447
1.94
20.12
12.2
6.7
mmol/l
1.1
1.4
8.71
251
1384
(3024980) IgG subclass 4 [Mass/volume] in Serum
73
221
3.39
20.04
1.4
1.6
g/l
0.4
0.9
3.50
60
172
(3010375) cycloSPORINE [Mass/volume] in Blood
37
66
5.69
19.94
35.1
32.6
ug/l
121.6
146.2
1.23
37
59
(4212803)
17
11
15.57
19.36
1.1
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
915
7062
1.54
19.36
2.3
2.0
pmol/l
94.2
93.8
0.10
560
3638
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
27
36
7.59
19.11
1.4
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
54
139
3.96
18.81
1.9
1.6
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
17
12
14.28
18.49
2.9
1.1
u/ml
36.6
19.0
0.56
17
12
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
192
978
2.06
18.22
18.7
4.5
mmol/l
24.3
24.0
0.89
180
883
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1729
15521
1.74
17.91
38.3
13.8
mg/l
23.7
25.0
0.93
1554
12127
(21494890) Protein electrophoresis panel - 24 hour Urine
55
150
3.74
17.68
2.9
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
226
1237
1.93
17.47
5.6
3.1
mmol/l
1.2
1.2
0.20
212
1039
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
43
100
4.37
17.13
1.3
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
307
1861
1.76
17.09
7.9
7.0
mmol/l
1.2
1.2
0.03
234
1424
(3026008) Bacteria identified in Urine by Culture
646
4731
1.53
16.79
3.4
3.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
86
319
2.77
16.69
2.2
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1282
10814
1.50
16.58
5.2
4.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
50
134
3.80
16.49
1.1
1.1
u/l
67.6
90.7
0.41
38
96
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
304
1865
1.74
16.17
8.1
7.0
kpa
5.0
5.1
1.51
288
1775
(3019309) Folate [Moles/volume] in Red Blood Cells
496
3456
1.57
15.99
1.9
1.8
nmol/l
1169.2
1172.4
0.03
394
2552
(3027801) Oxygen [Partial pressure] in Arterial blood
303
1865
1.73
15.92
8.1
7.0
kpa
12.3
11.7
0.85
287
1773
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
17
16
10.70
15.55
1.2
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
57
175
3.32
15.36
3.8
3.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
539
3857
1.54
15.33
1.5
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1454
12685
1.51
15.17
47.4
16.6
%
14.5
13.7
55.90
1443
12337
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
138
669
2.14
14.89
4.9
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
35
78
4.55
14.72
1.5
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
223
1284
1.83
14.66
5.0
5.4
ph
7.4
7.4
0.79
24
137
(3006922) Hepatitis E virus Ab [Presence] in Serum
37
87
4.31
14.56
1.1
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
225
1303
1.82
14.51
5.0
5.3
kpa
5.0
5.1
1.72
203
1200
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
33
71
4.71
14.48
3.2
4.4
—
—
—
0
0
(3035880) pH of Pleural fluid
35
80
4.43
14.27
1.6
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
11
12.81
14.26
7.4
1.3
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
16
16
10.07
14.03
2.6
1.4
ng/l
42.4
160.5
1.05
11
11
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
36
86
4.24
13.89
1.3
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
187
1042
1.87
13.63
2.6
2.1
nmol/l
11.3
14.5
5.50
161
895
(3022493) Free Hemoglobin [Mass/volume] in Plasma
32
71
4.56
13.54
1.8
4.2
mg/l
58.4
66.9
0.55
26
54
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
471
3352
1.53
13.50
4.0
4.1
ng/l
367.2
594.1
0.88
395
2795
(3016502) Oxygen saturation in Arterial blood
270
1687
1.69
13.31
8.5
7.3
%
94.7
95.0
0.18
259
1622
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
24
42
5.77
13.21
1.5
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
48
146
3.34
13.16
1.4
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
212
1242
1.79
13.13
5.0
5.3
mmol/l
1.5
1.6
0.18
159
887
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
33
77
4.34
13.13
1.7
6.2
—
63.4
—
0
21
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
28
57
4.97
13.11
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
53
172
3.14
13.09
2.7
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
75
295
2.60
13.03
1.7
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
53
173
3.12
12.97
2.7
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
53
174
3.10
12.84
2.7
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
120
584
2.12
12.84
1.4
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
126
627
2.08
12.72
2.9
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
791
6289
1.42
12.65
2.6
2.3
nmol/l
79.8
77.5
1.35
719
5469
(21491868) Cryoglobulin [Mass/volume] in Serum
27
55
4.96
12.63
1.8
1.3
g/l
0.3
0.1
—
7
7
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
53
176
3.06
12.60
2.7
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
173
967
1.86
12.48
5.3
5.8
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
17
7
24.46
12.46
3.6
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
18
9
20.16
12.45
1.1
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
47
147
3.25
12.34
8.3
3.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
245
1522
1.69
12.31
9.0
7.5
g/l
113.1
122.1
8.55
237
1469
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
50
163
3.12
12.27
1.2
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
53
179
3.01
12.25
2.7
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
50
165
3.08
12.03
2.6
1.7
u/ml
32.6
44.2
0.31
44
151
(3023419) Bacteria identified in Sputum by Culture
61
226
2.75
11.93
1.9
2.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
33
83
4.02
11.93
1.9
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
40
116
3.50
11.83
1.1
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
245
1539
1.67
11.79
15.4
3.6
kpa
4.8
4.6
0.70
237
1485
(3024522) Salmonella sp identified in Specimen by Organism specific culture
52
178
2.97
11.75
2.8
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
110
536
2.11
11.75
2.3
1.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
74
305
2.48
11.70
3.0
1.9
u/ml
622.8
56.5
0.48
66
244
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
82
3.95
11.29
1.2
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
23
45
5.16
11.26
1.0
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
918
7603
1.38
11.07
5.6
5.0
estimate
0.0
0.0
0.50
182
1358
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
12
11
10.97
11.06
1.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
32
84
3.85
10.93
10.7
3.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
69
286
2.46
10.80
1.1
1.3
miu/ml
222.1
231.1
0.04
13
119
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
13
14
9.34
10.77
4.8
6.1
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
13
14
9.34
10.77
4.8
6.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
32
85
3.81
10.76
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
32
85
3.81
10.76
1.1
1.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
914
7591
1.37
10.71
4.0
3.7
estimate
0.0
0.0
0.00
174
1346
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
58
223
2.65
10.60
1.3
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
148
830
1.84
10.57
10.0
9.0
mmol/l
24.4
24.3
0.21
139
760
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
48
168
2.90
10.46
1.4
1.7
—
1933.3
—
0
6
(3037522) Nuclear Ab [Titer] in Serum
282
1891
1.57
10.36
1.4
1.3
titre
551.2
566.2
0.03
50
425
(3009261) Glucose [Presence] in Urine by Test strip
922
7697
1.36
10.33
4.1
3.7
estimate
0.0
0.0
0.32
178
1296
(3047189) Immunofixation for 24 hour Urine
26
61
4.30
10.30
1.8
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
61
249
2.49
9.89
1.2
1.1
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
13
5
26.14
9.81
1.0
1.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
88
424
2.12
9.72
1.9
1.5
g/l
0.3
0.2
1.19
80
403
(3028626) Oxygen [Partial pressure] in Capillary blood
114
612
1.91
9.34
3.9
6.7
kpa
8.7
8.7
0.03
100
571
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
779
6410
1.35
9.28
4.2
4.0
ng/l
109.5
101.6
0.04
608
4742
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
107
564
1.95
9.25
1.5
1.6
—
220.0
—
0
27
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1543
14088
1.39
9.04
30.0
12.8
ml/min/173m2
76.2
76.8
0.52
1376
11248
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
79
377
2.14
8.96
1.3
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
133
761
1.80
8.92
1.5
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
56
4.14
8.72
1.4
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
93
483
1.97
8.42
2.9
3.7
mmol/l
24.5
24.7
0.25
78
422
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
87
445
2.00
8.23
1.5
1.6
iu/ml
2.0
6.2
0.29
27
101
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1062
9240
1.31
8.22
3.8
3.1
u/l
56.3
49.1
1.61
991
8404
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
21
50
4.23
8.20
1.2
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
21
50
4.23
8.20
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
175
1112
1.63
8.02
5.1
4.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
44
171
2.61
7.95
1.3
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
20
47
4.29
7.94
1.1
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
143
865
1.70
7.92
6.0
6.1
mmol/l
24.9
24.5
1.04
133
811
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
45
179
2.55
7.76
1.4
1.2
u/ml
6.1
5.9
0.03
19
88
(3019550) Sodium [Moles/volume] in Serum or Plasma
1732
16252
1.43
7.68
38.6
16.9
mmol/l
139.6
139.7
0.74
1705
15765
(3023103) Potassium [Moles/volume] in Serum or Plasma
1735
16287
1.43
7.66
41.2
17.0
mmol/l
4.0
4.0
4.55
1702
15765
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
138
835
1.70
7.64
10.3
10.3
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
11
6
18.42
7.60
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
11
6
18.42
7.60
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
11
6
18.42
7.60
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
11
6
18.42
7.60
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
11
6
18.42
7.60
1.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
19
45
4.25
7.47
1.2
1.6
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
16
33
4.88
7.41
1.3
1.2
ug/l
151.8
33.5
—
7
13
(3019225) pH of Specimen
230
1588
1.51
7.33
9.2
3.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
153
962
1.64
7.33
1.3
1.6
—
—
—
0
0
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
7
0
+∞
7.29
1.0
0.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
46
191
2.44
7.27
1.3
1.2
u/ml
5.1
3.1
0.23
16
68
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
41
162
2.56
7.19
1.1
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
195
1309
1.54
7.09
4.1
4.3
ng/l
90.0
91.4
0.08
172
1121
(3003181) Sodium [Moles/volume] in Urine
62
297
2.12
7.03
1.3
1.7
mmol/l
67.9
65.8
0.12
55
238
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
44
183
2.43
6.95
1.3
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742
16427
1.41
6.92
26.4
9.2
u/l
26.2
25.7
0.46
1714
15651
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
235
1651
1.48
6.87
2.7
3.3
ng/l
248.3
234.9
0.18
208
1530
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
23
68
3.41
6.70
1.4
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
15
32
4.71
6.69
1.2
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
67
338
2.02
6.65
2.7
1.6
u/ml
534.4
25.2
0.61
67
321
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
103
598
1.76
6.64
1.5
1.7
u/l
43.9
38.4
1.61
97
501
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
11
9
12.28
6.58
1.8
1.9
%
1.8
2.2
—
11
9
(3047007) Chlamydophila sp Ab [Presence] in Serum
45
195
2.34
6.51
1.2
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
75
399
1.91
6.40
1.2
1.1
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
10
7
14.35
6.39
1.8
6.0
mg/l
2.5
0.9
—
10
7
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
19
51
3.75
6.36
1.2
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
26
86
3.05
6.35
2.0
1.8
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
10
15
6.69
6.31
1.1
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
38
155
2.48
6.28
1.2
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
75
402
1.90
6.27
2.5
2.2
g/l
117.1
132.5
3.71
51
303
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
132
833
1.62
6.26
13.5
2.7
%
1.2
1.2
0.02
132
827
(40760512) CD34 cells/100 cells in Bone marrow
6
0
+∞
6.25
1.5
0.0
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
6
0
+∞
6.25
4.0
0.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
46
211
2.21
5.86
1.1
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
319
2434
1.37
5.86
24.8
29.2
inr
1.4
1.5
0.10
49
340
(3005322) IgE [Units/volume] in Serum or Plasma
133
859
1.59
5.75
2.0
1.3
u/ml
68.6
263.0
5.39
100
788
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
22
70
3.17
5.74
1.4
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
297
2248
1.38
5.73
1.7
1.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
158
1067
1.52
5.61
7.7
6.9
mmol/l
24.8
24.5
0.43
147
994
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
51
3.55
5.60
1.3
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
17
47
3.64
5.48
1.3
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
64
342
1.90
5.44
2.9
2.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
975
8670
1.24
5.32
3.0
2.7
—
—
—
0
0
(3017704) Immunofixation for Urine
26
96
2.73
5.27
1.7
1.2
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
197
1415
1.43
5.15
1.2
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
39
177
2.23
5.14
1.4
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
93
566
1.67
5.13
2.5
3.5
g/l
0.4
0.3
0.48
57
225
(3043410) Blood group antigens tested for on Red Blood Cells
15
40
3.77
5.09
4.7
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
65
358
1.84
5.06
2.9
2.5
%
14.4
16.6
2.60
33
193
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
10
19
5.28
5.04
1.3
1.4
%
2.4
4.6
—
5
10
(3002523) Influenza virus A Ag [Presence] in Specimen
39
179
2.20
5.01
1.4
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
26
99
2.65
4.99
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
172
1220
1.45
4.82
4.1
2.5
ml/min/173m2
62.6
63.2
0.07
87
494
(3011397) Hemoglobin [Presence] in Urine by Test strip
458
3773
1.28
4.81
3.9
3.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
109
703
1.58
4.79
5.5
5.1
%
1.6
1.7
0.02
104
667
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
9
10
9.03
4.78
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
24
90
2.69
4.75
1.6
1.5
u/l
5.2
6.4
0.15
17
42
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
17
52
3.29
4.75
6.4
1.1
u/ml
9.1
34.2
—
5
11
(40761535) Cells panel - Urine sediment
190
1380
1.42
4.68
4.1
3.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
43
213
2.04
4.58
2.2
1.9
%
88.2
89.8
0.82
43
208
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
35
160
2.21
4.57
1.1
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
13
34
3.84
4.53
1.2
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
13
34
3.84
4.53
2.2
1.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1254
11558
1.22
4.49
3.9
3.7
pmol/l
15.0
15.0
0.32
1140
10305
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
30
4.02
4.43
4.8
6.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
37
177
2.11
4.33
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
76
460
1.68
4.33
1.7
1.7
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
12
31
3.89
4.25
1.8
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
105
692
1.55
4.23
5.6
5.1
%
0.9
0.9
0.22
99
656
(3034426) Prothrombin time (PT)
15
46
3.28
4.19
1.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
125
859
1.48
4.15
4.6
3.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
68
2.81
4.12
1.1
1.1
—
—
—
0
0
(4268621)
29
129
2.27
4.06
2.4
2.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
10
8.02
4.06
1.3
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
10
8.02
4.06
1.7
1.3
—
—
—
0
0
(3013512) EKG study
556
4767
1.23
4.02
4.6
4.3
—
—
—
0
0
(4306422)
36
176
2.06
4.01
1.1
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
65
386
1.71
3.99
1.4
1.4
ug/g
274.9
302.1
0.57
40
233
(3041096) Erythrocytes [Presence] in Urine by Automated
465
3918
1.24
3.95
3.9
3.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
13
38
3.44
3.90
2.0
3.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
38
192
2.00
3.88
1.4
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
81
514
1.60
3.87
4.5
4.2
mmol/l
4.0
3.9
0.48
75
476
(3011648) Oxygen content in Venous blood
30
139
2.18
3.83
45.8
2.3
%
10.3
11.0
0.45
30
139
(3033705) Calcium.ionized [Moles/volume] in Venous blood
42
221
1.92
3.83
3.1
2.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
62
368
1.71
3.83
5.0
4.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
13
39
3.35
3.76
1.4
1.3
%
86.0
103.0
0.66
13
34
(40768797) Stomach Pathology biopsy report
257
2032
1.30
3.69
1.3
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
209
1606
1.34
3.67
4.8
3.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
12
6.69
3.67
1.8
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
40
3.26
3.62
2.1
2.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
12
35
3.44
3.62
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
98
661
1.51
3.60
2.1
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
71
445
1.62
3.59
5.3
4.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
62
377
1.66
3.53
1.1
1.2
titre
127.1
83.8
—
7
29
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
659
5813
1.20
3.48
4.3
3.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
18
69
2.62
3.47
1.0
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
59
356
1.68
3.46
6.0
4.6
mmol/l
2.2
2.7
0.79
40
233
(3029937) Albumin [Presence] in Urine by Test strip
485
4165
1.22
3.39
4.2
4.0
estimate
0.0
0.0
1.08
172
1299
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
18
5.02
3.37
1.3
1.1
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
7
10
7.02
3.36
1.3
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
27
3.72
3.35
1.2
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
14
5.73
3.34
1.0
1.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
7
8.59
3.26
10.2
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
9
19
4.75
3.24
3.0
1.2
—
—
—
0
0
(3010421) pH of Blood
66
418
1.60
3.23
5.7
4.4
ph
7.4
7.4
1.35
56
349
(3009871) Measles virus Ab [Titer] in Serum
11
33
3.35
3.19
2.0
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
49
2.87
3.19
2.4
2.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
60
373
1.63
3.17
25.9
3.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1457
13814
1.19
3.15
42.3
15.3
%
37.1
39.4
13.71
967
9105
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
17
67
2.55
3.12
1.9
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
62
392
1.60
3.07
3.3
3.2
nmol/l
0.8
0.8
0.15
41
299
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
8
16
5.01
3.05
1.4
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
17
68
2.51
3.04
1.1
1.0
—
—
—
0
0
(3020891) Body temperature
100
704
1.44
3.01
4.6
4.7
—
—
—
0
0
(4281824)
16
63
2.55
2.95
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
1162
10856
1.16
2.87
4.5
4.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
20
90
2.23
2.80
1.8
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
14
53
2.65
2.79
1.1
1.3
—
—
—
0
0
(4015189)
14
53
2.65
2.79
2.9
1.9
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
75
510
1.49
2.72
6.5
6.4
mmol/l
1.2
1.3
0.45
67
451
(3034770) Mitochondria Ab [Titer] in Serum
60
390
1.55
2.68
1.1
1.2
—
1728.2
—
0
11
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
8
19
4.22
2.68
1.1
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
8
19
4.22
2.68
1.4
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
20
4.01
2.56
1.3
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
120
1579
0.74
2.54
1.5
1.6
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
11
5.47
2.54
1.3
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
15
62
2.43
2.54
1.0
1.1
ng/l
995.8
89.6
—
5
16
(3024869) Neuronal Ab [Presence] in Serum
10
33
3.04
2.52
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
19
88
2.17
2.51
3.6
2.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
19
89
2.15
2.45
1.8
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
32
181
1.78
2.44
1.3
1.4
pmol/l
458.0
354.0
0.37
32
130
(3020682) Albumin/Creatinine [Ratio] in Urine
499
5605
0.85
2.42
4.0
4.1
mg/mmol
16.8
11.7
0.59
347
3615
(3027570) Oxalate [Moles/time] in 24 hour Urine
6
12
5.01
2.40
1.0
1.4
umol/24h
440.2
368.6
—
6
12
(3045424) Erythrocytes [Presence] in Urine
37
220
1.69
2.38
1.4
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
579
5191
1.16
2.38
2.3
2.2
u/l
186.0
248.0
1.15
533
4828
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
22
3.65
2.36
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
175
1400
1.27
2.35
1.6
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
156
1230
1.29
2.35
4.0
3.9
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
16
71
2.26
2.34
1.0
1.1
u/l
51.8
28.7
—
10
49
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
23
3.49
2.27
1.4
1.9
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
30
171
1.77
2.25
1.4
1.5
mosm/kgh2o
279.9
278.0
0.19
23
121
(1761868) Lipid panel - Serum or Plasma
408
4626
0.85
2.21
3.1
3.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
20
100
2.01
2.20
3.3
3.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
21
107
1.97
2.20
1.5
1.6
umol/l
12.2
14.3
0.83
21
97
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
21
107
1.97
2.20
1.2
1.1
mg/l
54.5
35.3
0.76
16
91
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1477
14169
1.15
2.19
4.7
4.5
mu/l
2.2
2.2
0.08
1360
12703
(3004451) EKG impression Narrative
17
81
2.11
2.12
1.2
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
140
1107
1.28
2.09
1.6
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
43
276
1.57
2.09
1.1
1.4
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
10
5.01
2.07
1.4
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
6
15
4.01
2.04
1.3
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
10
38
2.64
2.01
1.4
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
28
462
0.60
1.97
1.3
1.6
mg/l
4.1
4.3
0.03
19
333
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
25
141
1.78
1.97
1.8
2.1
u/field
1.6
1.8
0.12
12
49
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
5
11
4.55
1.94
1.2
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
747
6904
1.13
1.90
4.9
3.9
ug/l
6.9
2.7
0.50
669
6135
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
5
12
4.17
1.82
1.4
1.3
pmol/l
21.7
14.9
—
5
12
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
7
23
3.05
1.80
2.9
6.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
7
23
3.05
1.80
1.4
3.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
29
2.76
1.79
1.4
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
11
47
2.35
1.77
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
204
1719
1.21
1.76
1.8
2.5
ug/g
167.6
152.3
0.17
154
1348
(3015171) Extractable nuclear Ab [Units/volume] in Serum
71
525
1.36
1.73
1.2
1.2
u/ml
0.3
0.8
—
9
49
(3051387) C reactive protein [Mass/volume] in Capillary blood
54
381
1.43
1.73
4.5
3.5
mg/l
35.6
29.5
0.46
38
254
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
30
2.67
1.72
1.4
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
199
1679
1.21
1.70
2.3
2.5
ug/l
7.4
7.8
0.08
159
1443
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
82
1.96
1.69
1.0
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1766
17260
1.17
1.67
55.3
20.1
e9/l
202.9
242.8
84.68
1735
16664
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
60
435
1.39
1.66
1.3
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
44
301
1.47
1.66
1.7
2.2
u/l
11448.1
3174.8
0.48
13
121
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
84
1086
0.76
1.65
1.6
2.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1767
17274
1.17
1.65
55.5
20.2
g/l
126.3
135.9
93.68
1749
16917
(21494755) Public health laboratory ask at order entry panel
62
837
0.73
1.64
1.4
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
1766
17265
1.17
1.64
55.1
20.0
fl
93.0
91.1
34.02
1747
16910
(4146454)
10
212
0.47
1.64
2.1
2.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
1766
17267
1.17
1.63
55.0
20.0
pg
30.6
30.4
5.73
1747
16913
(3026361) Erythrocytes [#/volume] in Blood
1766
17268
1.17
1.62
55.3
20.1
e12/l
4.2
4.5
75.72
1729
16591
(3010813) Leukocytes [#/volume] in Blood
1766
17270
1.17
1.61
55.4
20.1
e9/l
16.6
6.9
53.60
1730
16602
(3014765) Yersinia sp identified in Stool by Organism specific culture
60
439
1.38
1.58
1.3
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
41
280
1.47
1.57
1.2
1.2
u/ml
22.4
49.3
—
6
26
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
92
722
1.29
1.53
3.3
3.0
pmol/l
4.4
4.6
0.59
79
629
(3014051) Protein [Presence] in Urine by Test strip
51
366
1.40
1.52
2.6
2.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
60
443
1.36
1.51
1.3
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
45
0.00
1.49
0.0
5.0
—
53.9
—
0
9
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
37
2.44
1.48
1.1
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
380
4205
0.88
1.44
2.1
1.6
mmol/l
1.4
1.3
0.76
333
3489
(40761511) CBC panel - Blood by Automated count
1644
16027
1.13
1.44
25.6
13.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
486
5296
0.89
1.43
3.3
3.3
mg/l
1469.2
177.7
2.93
351
3407
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
42
587
0.71
1.41
1.4
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
28
181
1.55
1.40
1.6
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
20
119
1.69
1.37
1.2
1.3
mmol/l
9.6
11.1
—
5
33
(4027681)
15
82
1.84
1.35
1.4
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
127
1053
1.22
1.34
3.5
3.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
38
0.00
1.34
0.0
1.8
—
4.9
—
0
11
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
68
875
0.77
1.34
2.1
1.7
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
42
2.15
1.33
2.3
1.2
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
40
0.00
1.32
0.0
1.3
—
20.6
—
0
30
(3008898) HLA-B27 [Presence]
28
415
0.67
1.31
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
18
106
1.70
1.29
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
18
106
1.70
1.29
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
18
106
1.70
1.29
1.1
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
33
226
1.47
1.29
5.9
8.7
mmol/l
8.8
7.5
0.66
28
185
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
97
1188
0.81
1.27
1.6
2.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
241
0.58
1.24
1.2
1.2
u/ml
4.5
7.7
—
7
153
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22
139
1.59
1.23
1.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
19
2.64
1.21
1.4
3.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
14
239
0.58
1.21
1.9
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
18
109
1.66
1.18
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
18
109
1.66
1.18
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
18
109
1.66
1.18
1.1
1.2
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
6
26
2.31
1.18
7.7
5.8
mg/l
1.1
1.8
—
6
19
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
237
0.59
1.18
1.2
1.2
u/ml
0.1
1.5
—
7
135
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
62
481
1.30
1.18
1.9
1.8
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
20
2.50
1.15
2.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
103
852
1.22
1.15
2.5
2.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
29
199
1.46
1.14
1.6
1.3
nmol/l
0.6
0.6
0.15
29
190
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
29
199
1.46
1.14
1.6
1.3
nmol/l
0.2
0.4
—
5
15
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
51
387
1.33
1.14
1.3
1.2
u/ml
1.7
3.2
—
5
37
(3009508) Creatinine [Moles/volume] in Urine
527
5646
0.91
1.10
3.2
3.3
mmol/l
7.3
7.6
0.51
453
4726
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
21
2.38
1.09
2.0
2.6
u/field
0.6
0.4
—
5
21
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
41
1.95
1.08
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
32
2.19
1.08
1.4
2.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
51
391
1.31
1.07
1.3
1.2
u/ml
2.5
7.3
—
7
62
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
179
0.56
1.05
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
179
0.56
1.05
1.5
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
17
265
0.64
1.05
1.4
1.2
u/ml
1.2
2.3
—
8
140
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
178
0.56
1.03
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
178
0.56
1.03
1.5
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
46
597
0.77
1.02
1.8
1.9
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
53
1.89
1.01
1.1
1.1
miu/ml
625.4
1565.3
—
10
53
(40768446) Kidney Pathology biopsy report
12
68
1.77
1.00
1.1
1.8
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
0
29
0.00
0.97
0.0
1.2
—
3.8
—
0
24
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
199
0.60
0.97
1.6
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
32
0.00
0.95
0.0
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
52
1.73
0.92
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
28
201
1.40
0.91
1.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
413
3842
1.09
0.89
3.0
2.7
ug/l
0.8
0.8
0.17
296
2649
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
30
2.00
0.87
1.2
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
31
1.94
0.84
1.3
1.5
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
6
32
1.88
0.81
1.0
1.3
nmol/l
12.3
692597.4
—
6
27
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
34
258
1.32
0.81
3.0
3.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
76
637
1.20
0.80
1.1
1.1
—
1.8
—
0
7
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
33
1.82
0.79
1.5
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
98
0.51
0.78
4.0
1.6
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.2
—
4.1
—
0
21
(3022689) Creatine [Moles/volume] in Urine
9
54
1.67
0.74
2.2
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
207
2271
0.90
0.73
1.2
1.2
u/ml
6.6
12.8
1.18
65
840
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
187
2060
0.90
0.71
4.1
4.9
%
31.3
33.0
1.24
133
1341
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
26
1.93
0.70
2.8
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
142
0.63
0.69
2.4
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
9
143
0.63
0.69
1.6
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
144
0.62
0.69
1.6
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
134
1502
0.88
0.69
1.6
1.7
%
1.6
1.6
0.02
118
1287
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
146
0.61
0.69
1.7
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
42
1.67
0.68
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
42
1.67
0.68
1.3
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
26
196
1.33
0.67
1.2
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
28
1.79
0.66
2.6
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
380
3579
1.08
0.63
4.4
4.0
kg/l
1.0
1.0
0.36
47
543
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
173
1.33
0.61
1.5
1.3
nmol/l
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
30
1.67
0.61
1.4
1.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
50
1.60
0.61
1.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
52
1.54
0.59
1.0
1.2
—
—
—
0
0
(4034850)
48
569
0.84
0.55
14.7
10.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
77
674
1.15
0.54
1.4
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
99
1.42
0.54
1.1
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
9
63
1.43
0.52
1.6
1.8
ug/l
8.9
149.6
—
9
55
(3044941) Cell count panel - Synovial fluid
22
281
0.78
0.51
1.6
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
134
1221
1.10
0.50
1.2
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
16
118
1.36
0.50
1.0
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
25
199
1.26
0.48
2.0
2.4
mg/l
43.4
20.9
—
5
39
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
200
2144
0.93
0.47
10.7
7.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
35
416
0.84
0.44
1.8
2.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
51
1.37
0.44
2.4
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
51
1.37
0.44
2.4
2.5
—
—
—
0
0
(4198724)
8
56
1.43
0.42
1.9
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
162
0.74
0.42
1.8
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
41
478
0.85
0.42
1.5
1.8
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
32
1.56
0.42
1.8
1.5
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
8
57
1.40
0.42
1.5
1.9
nmol/l
1.9
5.6
—
8
45
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
23
185
1.25
0.42
1.0
1.0
g/l
1.5
1.5
0.06
18
161
(3003338) MCHC [Mass/volume]
1317
12966
1.04
0.41
51.1
18.1
g/l
329.8
332.8
20.55
1309
12844
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
15
0.00
0.41
0.0
5.3
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
166.5
—
0
8
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
22.0
—
0
9
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
3.1
—
0
10
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
88
1.37
0.40
1.6
1.5
g/l
1.1
0.9
0.38
12
88
(3044242) Glucose [Moles/volume] in Arterial blood
7
101
0.69
0.39
3.3
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
35
1.43
0.39
1.6
1.7
—
—
—
0
0
(4133840)
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.7
—
2.4
—
0
14
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
11
80
1.38
0.38
1.3
1.3
mmol/l
5.8
6.3
0.63
11
75
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
107
1.31
0.37
1.7
1.4
u/ml
0.3
1.4
—
7
54
(40768441) Liver Pathology biopsy report
9
69
1.31
0.37
1.1
1.6
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
37
1.35
0.37
2.6
6.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
224
0.80
0.37
1.6
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
14
180
0.78
0.37
1.6
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
71
1.27
0.36
1.2
1.2
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
6
42
1.43
0.35
1.5
9.1
g/mol
47.0
1272.2
—
6
36
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
79
0.63
0.35
1.0
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
191
1.21
0.33
1.9
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
30
349
0.86
0.32
1.9
2.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1476
14913
0.96
0.32
4.3
4.6
mmol/l
1.3
1.4
21.26
1348
13527
(3004616) Nuclear Ab [Presence] in Serum
24
201
1.20
0.32
1.1
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1454
14385
1.04
0.31
4.3
4.2
mmol/l
1.3
1.3
2.45
1333
12936
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
75
1.33
0.30
1.0
1.0
—
—
—
0
0
(44806420)
7
57
1.23
0.29
1.7
2.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
31
270
1.15
0.28
2.0
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
90
836
1.08
0.27
1.1
1.2
iu/ml
168.4
140.2
0.25
28
311
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
72
0.69
0.26
19.8
15.8
nmol/l
185067.4
1309.1
—
5
72
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
382
3706
1.04
0.26
1.6
1.7
pmol/l
137855316.7
30073366.0
0.62
317
3016
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
127
0.79
0.25
1.6
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
15
123
1.22
0.25
1.4
1.3
promille
1.1
1.2
—
9
94
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
123
1.22
0.25
1.3
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
9
76
1.18
0.24
2.2
2.5
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
10
126
0.79
0.24
1.2
1.0
ng/l
39.8
49.8
—
5
73
(3011288) Drugs identified in Urine by Screen method
27
306
0.88
0.23
2.8
3.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
39
1.28
0.23
7.6
8.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
68
731
0.93
0.22
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
14
116
1.21
0.22
1.0
1.0
mg/l
299.3
286.4
—
9
103
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
267
1.13
0.21
1.5
1.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(44806071)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000492) Spirometry study
125
1313
0.95
0.21
1.7
1.5
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
8
103
0.78
0.21
1.1
1.1
—
12.2
—
0
20
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
15
126
1.19
0.21
1.1
1.1
—
4.8
—
0
6
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
2.6
—
0
6
(3040893) Potassium [Moles/volume] in Capillary blood
0
13
0.00
0.21
0.0
3.2
—
4.3
—
0
13
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
42
459
0.91
0.20
1.5
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
44
479
0.92
0.19
2.0
2.2
ug/min
224.2
101.3
0.35
26
292
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1501
15109
0.97
0.19
5.2
4.9
mmol/l
6.0
6.1
0.11
1377
13523
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
16
186
0.86
0.19
1.6
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
47
509
0.92
0.19
1.6
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
52
1.15
0.19
1.2
2.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
40
366
1.09
0.19
2.6
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
46
424
1.09
0.18
1.8
1.6
e6/l
18112.9
14425.1
0.16
35
311
(3024263) Appearance of Synovial fluid
12
100
1.20
0.18
2.6
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
40
435
0.92
0.18
1.7
2.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
28
310
0.90
0.17
1.7
1.9
iu/l
11.8
4.3
—
10
99
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
230
2366
0.97
0.16
1.2
1.3
iu/ml
60.0
38.8
0.71
64
708
(3006576) Bicarbonate [Moles/volume] in Blood
8
72
1.11
0.16
6.0
7.2
mmol/l
21.5
24.9
—
8
65
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
78
1.15
0.15
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
41
441
0.93
0.15
1.7
2.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
11
129
0.85
0.14
1.5
3.1
mmol/l
7.6
6.8
0.51
11
86
(3038177) Helicobacter pylori Ab [Presence] in Serum
21
188
1.12
0.14
1.1
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
88
0.79
0.14
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
92
961
0.96
0.14
1.2
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
19
212
0.90
0.14
2.0
2.6
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
18
160
1.13
0.14
1.2
1.2
e6/l
380517.0
191480.6
0.20
13
112
(3051593) INR in Capillary blood by Coagulation assay
12
103
1.17
0.13
11.2
11.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
41
438
0.93
0.13
1.7
2.2
—
—
—
0
0
(44813793)
11
94
1.17
0.13
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
333
3270
1.02
0.12
1.3
1.3
u/ml
1.6
1.9
0.16
70
790
(4010399)
122
1180
1.04
0.12
1.4
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
12
104
1.15
0.12
5.8
3.0
%
14.0
13.2
1.55
12
104
(3020961) Endomysium IgA Ab [Titer] in Serum
73
698
1.05
0.12
1.1
1.1
—
167.4
—
0
17
(3000764) Benzodiazepines [Presence] in Urine
41
436
0.94
0.12
1.7
2.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
564
5571
1.02
0.12
4.3
3.8
%
22.6
24.3
1.88
284
2743
(4094501)
44
415
1.06
0.11
1.0
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
11
126
0.87
0.11
1.2
1.0
ng/l
242.4
347.7
—
5
76
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
50
475
1.05
0.10
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
42
444
0.94
0.10
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
27
251
1.08
0.10
1.6
1.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
63
0.79
0.08
6.2
7.3
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
5
64
0.78
0.08
1.0
1.0
mu/l
5.6
7.8
—
5
64
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
72
0.83
0.07
2.0
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
38
398
0.95
0.07
1.5
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
76
1.05
0.07
3.4
3.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
27
286
0.94
0.07
1.1
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
80
0.87
0.07
1.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1537
15407
0.99
0.06
4.8
5.3
mmol/l
2.6
2.6
0.11
1401
14014
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
15
139
1.08
0.05
1.1
1.1
—
63.2
—
0
13
(3035320) C reactive protein [Mass/volume] in Body fluid
12
110
1.09
0.05
3.0
2.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
170
0.94
0.04
1.1
1.1
u/ml
1.3
2.8
—
6
62
(3038026) Centromere Ab [Units/volume] in Serum
15
141
1.06
0.03
1.1
1.1
—
54.8
—
0
6
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
17
179
0.95
0.03
1.2
1.3
mmol/l
7.4
7.9
—
10
124
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1507
15047
1.01
0.03
4.5
4.7
mmol/l
4.3
4.4
2.91
1380
13752
(3021788) Differential panel - Synovial fluid
29
298
0.97
0.02
1.8
1.5
—
—
—
0
0
(4024509)
14
146
0.96
0.00
1.6
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
15
144
1.04
0.00
1.1
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
108
1.02
0.00
1.4
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
108
1.02
0.00
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
16
162
0.99
0.00
1.1
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1441
14404
1.00
0.00
5.9
6.4
mmol/mol
39.3
40.7
6.36
1316
13189
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
36
363
0.99
0.00
1.2
1.8
nmol/l
1.1
0.8
1.62
29
297
(3000034) Microalbumin [Mass/volume] in Urine
16
165
0.97
0.00
4.9
3.2
mg/l
11.6
25.9
—
9
131
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
91
0.99
0.00
2.9
2.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
57
0.88
0.00
6.4
7.3
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
4.2
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
58
0.86
0.00
1.0
1.2
—
16.3
—
0
8
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
79
1.01
0.00
1.0
1.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
5
50
1.00
0.00
1.0
1.1
%
92.6
93.0
—
5
40
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
8
85
0.94
0.00
3.4
3.7
—
—
—
0
0
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
8
0.00
0.00
0.0
1.0
—
160.3
—
0
8
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.8
—
3.6
—
0
6
(3036525) Urea [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: CD2_LYMPHOID_LEUKAEMIA_EXALLC – Lymphoid leukaemia

GWS hits: 12

This endpoint is excluded (different definition than used in FinnGen).